Eleanore R Hobbs, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 126 6th Ave. Sw, St. Luke Community Clinci Ronan, Ronan, MT 59864 Phone: 406-676-4441 Fax: 406-676-0835 |
News Archive
Researchers at the Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK, have found that late developers may run a higher risk of infection than sexually mature younger teens.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
Large quantities of rich Christmas food appear to boost Danes' cholesterol levels. Right after the Christmas break, levels are 20% higher than in the summer.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
Professor Jo Milner and Dr Shafiq Ahmed, from the YCR P53 Research Unit in the Department of Biology, used a process called RNA interference to target the JNK2 gene in both cancer and healthy cells. The cancer cells died but the healthy cells were unaffected.
› Verified 8 days ago